Remifentanil
- Generic Name
- Remifentanil
- Brand Names
- Ultiva
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28N2O5
- CAS Number
- 132875-61-7
- Unique Ingredient Identifier
- P10582JYYK
- Background
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
- Indication
For use during the induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy
- Conditions
- Interventions
- First Posted Date
- 2017-07-27
- Last Posted Date
- 2017-07-27
- Lead Sponsor
- KK Women's and Children's Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT03231683
- Locations
- 🇸🇬
Kk Women'S and Children'S Hospital, Singapore, Singapore
The Effects of General Anesthetics on Lymphocytes in Patients Undergoing Colorectal Cancer Resection and Mechanism Involved
- First Posted Date
- 2017-06-21
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Guizhi Du
- Target Recruit Count
- 260
- Registration Number
- NCT03193710
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Department of Anesthesiology, Chengdu, Sichuan, China
CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
- Conditions
- Interventions
- First Posted Date
- 2017-05-30
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- KK Women's and Children's Hospital
- Target Recruit Count
- 881
- Registration Number
- NCT03167905
- Locations
- 🇸🇬
KK Women's and Children's Hospital, Singapore, Singapore
Analysis of Change of Optic Nerve Sheath Diameter in Robot Assisted Laparoscopic Radical Prostatectomy
- Conditions
- Interventions
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Seoul National University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03152981
- Locations
- 🇰🇷
Seoul National Univ. Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Pharmacodynamic Interaction of REMI and DMED
- First Posted Date
- 2017-05-08
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- University Medical Center Groningen
- Target Recruit Count
- 30
- Registration Number
- NCT03143972
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
The Epigenetic Modification in OPRM1 on Postoperative Analgesia and Side Effect Induced by Sufentanil
- First Posted Date
- 2017-05-01
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 100
- Registration Number
- NCT03135795
- Locations
- 🇨🇳
Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Optimal Remifentanil Ce for Preventing Severe Cough and Hyperdynamic Response During Tracheal Extubation
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- Fundacion Clinica Valle del Lili
- Target Recruit Count
- 364
- Registration Number
- NCT03132519
- Locations
- 🇨🇴
Fundacion Valle del Lili, Cali, Valle, Colombia
OFA - Opioid Free Anesthesia
- Conditions
- Interventions
- First Posted Date
- 2017-04-21
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- University of Parma
- Target Recruit Count
- 64
- Registration Number
- NCT03124082
- Locations
- 🇮🇹
University Hospital, Parma, Italy
Remifentanil and Hyperalgesia: Gradual Withdrawal Versus Immediate Discontinuation
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2017-10-18
- Lead Sponsor
- Université Libre de Bruxelles
- Target Recruit Count
- 30
- Registration Number
- NCT03110653
- Locations
- 🇧🇪
Erasme Hospital, Brussels, Belgium
Heart Rate Variability Under Propofol and Sevoflurane
- Conditions
- Interventions
- First Posted Date
- 2017-04-04
- Last Posted Date
- 2017-04-04
- Lead Sponsor
- Hôpital Armand Trousseau
- Target Recruit Count
- 40
- Registration Number
- NCT03098875
- Locations
- 🇫🇷
Departement d'anesthesie Hopital Armand Trousseau, Paris, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.